(Total Views: 364)
Posted On: 01/05/2018 10:44:17 AM
Post# of 75449
Choosing now to go into Mexico was a really savvy move, IMHO. It's a great risk-diversification option, what with the risk posed by Session's pot-phobia in the US.
I also believe a lot of us tend to underestimate the potential of the Mexico market. It's the second largest market in Latin America with a population of about 120 million.
And better yet, going into Mexico is actually shorthand for 'going into Latin America.' All of it.
(That's right, folks. Mexico is a gateway drug I mean country.)
If I'd been hired as a strategic consultant by RMHB, I would have recommended: 1) having a product line that's marijuana-independent; 2) going into markets where the regulatory environment seems pretty settled; and 3) looking for an acquisition that will provide dependable revenues that are not entirely subject to the vagaries of the emerging THC/CBD marketplace. And wait ... hold on ... that's exactly what management did!
Why I feel good, finally, about this company.
I also believe a lot of us tend to underestimate the potential of the Mexico market. It's the second largest market in Latin America with a population of about 120 million.
And better yet, going into Mexico is actually shorthand for 'going into Latin America.' All of it.
(That's right, folks. Mexico is a gateway drug I mean country.)
If I'd been hired as a strategic consultant by RMHB, I would have recommended: 1) having a product line that's marijuana-independent; 2) going into markets where the regulatory environment seems pretty settled; and 3) looking for an acquisition that will provide dependable revenues that are not entirely subject to the vagaries of the emerging THC/CBD marketplace. And wait ... hold on ... that's exactly what management did!
Why I feel good, finally, about this company.
(19)
(0)
